Programmable implantable insulin infusion devices and diabetes care

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Programmable implantable insulin infusion devices and diabetes care

Abstract

References

Implantable programmable insulin pumps for the treatment of diabetes

Controversial beliefs about diabetes and its care

Changes in hepatic glutathione metabolism in diabetes.

Normalization of composition of triglyceride-rich lipoprotein subfractions in diabetic subjects during insulin infusion with programmable implantable medication system.

Randomized comparison of metabolic control achieved by intraperitoneal insulin infusion with implantable pumps versus intensive subcutaneous insulin therapy in type I diabetic patients.

Importance of insulin in subjective, cognitive, and hormonal responses to hypoglycemia in patients with IDDM

Major cross-country differences in risk of dying for people with IDDM. Diabetes Epidemiology Research International Mortality Study Group.

Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites, and hormones in type I diabetes mellitus

A preliminary trial of the programmable implantable medication system for insulin delivery

Immunogenicity of intraperitoneal insulin infusion using programmable implantable devices

Immunogenicity of long-term intraperitoneal insulin administration with implantable programmable pumps. Metabolic consequences

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial

Development of the implantable glucose sensor. What are the prospects and why is it taking so long?

Diagnostic procedures for catheter malfunction in programmable implantable intraperitoneal insulin infusion devices

Variation in office-based quality. A claims-based profile of care provided to Medicare patients with diabetes

Intraperitoneal insulin delivery decreases the levels of chylomicron remnants in patients with IDDM

French multicentre experience of implantable insulin pumps. The EVADIAC Study Group. Evaluation of Active Implants in Diabetes Society

Insulin antibody responses after long-term intraperitoneal insulin administration via implantable programmable insulin delivery systems

Alterations in reverse cholesterol transport associated with programmable implantable intraperitoneal insulin delivery

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

A comparison of renal disease across two continents; the epidemiology of diabetes complications study and the EURODIAB IDDM Complications Study

Comparisons of studies on diabetic complications hampered by differences in GHb measurements

Beyond LDL cholesterol reduction

Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group

Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group

Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM

Catheter survival during long-term insulin therapy with an implanted programmable pump. The Implantable Insulin Pump Trial Study Group

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study

Advances toward the implantable artificial pancreas for treatment of diabetes

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

Arrhythmias and mortality after myocardial infarction in diabetic patients. Relationship to diabetes treatment

Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects

Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study

Genetic influence of the R/Q353 genotype on factor VII activity is overwhelmed by environmental factors in Chinese patients with Type II (non-insulin-dependent) diabetes mellitus

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

The Veterans Affairs Implantable Insulin Pump Study: effect on cardiovascular risk factors

Citations

Investigation of the specificity of Raman spectroscopy in non-invasive blood glucose measurements.

In vivo glucose sensing for diabetes management: progress towards non-invasive monitoring. Interview by Judy Jones

Understanding HIV resistance, fitness, replication capacity and compensation: targeting viral fitness as a therapeutic strategy

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Related Papers

Effect of photobleaching on calibration model development in biological Raman spectroscopy

Non-invasive blood glucose monitoring by means of near infrared spectroscopy: investigation of long-term accuracy and stability

Effect of hemoglobin concentration variation on the accuracy and precision of glucose analysis using tissue modulated, noninvasive, in vivo Raman spectroscopy of human blood: a small clinical study

Glucose determination in human aqueous humor with Raman spectroscopy

Bloodless glucose measurements